Clariane SE (CHIX:CLARIP) Other Long Term Assets: €371 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:CLARIP Clariane SE CHIX:CLARIP
60 GF Score
Price €4.06
GF Value €2.54
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clariane SE Other Long Term Assets?

Clariane SE CHIX:CLARIP 60 Other Long Term Assets is €371 Mil as of Jun. 2026. GuruFocus rates CHIX:CLARIP with a GF Score™ of 60/100 and a GF Value™ of €2.54 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Clariane SE's other long-term assets for the quarter that ended in Jun. 2026 was €371 Mil.

Clariane SE's quarterly other long-term assets increased from Jun. 2025 (€341 Mil) to Dec. 2025 (€375 Mil) but then stayed the same from Dec. 2025 (€375 Mil) to Jun. 2026 (€371 Mil).

Clariane SE's annual other long-term assets increased from Dec. 2023 (€255 Mil) to Dec. 2024 (€319 Mil) and increased from Dec. 2024 (€319 Mil) to Dec. 2025 (€375 Mil).

Clariane SE Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Clariane SE's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Other Long Term Assets Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.62 157.41 255.18 319.37 374.56

Clariane SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 281.83 319.37 340.81 374.56 370.89
CHIX:CLARIP
60GF Score
Clariane SE CHIX:CLARIP
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of €371 Mil mean?
Clariane SE (CHIX:CLARIP) has a Other Long Term Assets of €371 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Clariane SE and its competitors.
Is Clariane SE's Other Long Term Assets too high?
Clariane SE's current Other Long Term Assets is €371 Mil. Overall, Clariane SE has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Other Long Term Assets compare to HCA and THC?
Clariane SE's Other Long Term Assets of €371 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Clariane SE and its competitors. Clariane SE's current Other Long Term Assets is €371 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.54, compared to a current price of €4.06 — trading 59.8% above its estimated fair value. The current Other Long Term Assets is €371 Mil. Clariane SE's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Other Long Term Assets is €371 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.06 is trading 59.8% above its estimated GF Value™ of €2.54. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for CHIX:CLARIP:

  • Other Long Term Assets: €371 Mil
  • GF Value™: €2.54 vs. price of €4.06 (59.8% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
60GF Score

Get the complete analysis for CHIX:CLARIP

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.06
Price
€2.54
GF Value